id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0194-0001,FDA,FDA-2005-P-0194,Acknowledgment Letter from FDA DDM to Warren Rucker,Other,Acknowledgement Letter/Receipt,2005-12-30T05:00:00Z,2005,12,,,2018-08-13T15:51:37Z,,0,0,0900006480440eae
FDA-1992-V-0009-0002,FDA,FDA-1992-V-0009,Variance Approval from FDA CDRH to Jeff Cone Studios,Other,Approval for Variance (VRA),2005-12-30T05:00:00Z,2005,12,,,2015-09-25T18:15:32Z,,0,0,0900006480525e9e
FDA-2003-N-0163-0001,FDA,FDA-2003-N-0163,FDA,Notice,NWL-Notice of Withdrawl,2005-12-29T05:00:00Z,2005,12,2005-12-27T05:00:00Z,,2008-04-12T00:59:12Z,,0,0,09000064804886b0
FDA-2005-P-0123-0001,FDA,FDA-2005-P-0123,"Determination That DECADRON (Dexam@thasone) Tablets, 1.5 Milligrams,
Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,N-Notice,2005-12-29T05:00:00Z,2005,12,2005-12-27T05:00:00Z,,2024-12-13T19:52:31Z,,0,0,090000648043fc0c
FDA-2005-N-0467-0001,FDA,FDA-2005-N-0467,Animal Drug User Fee Act; Public Meeting,Notice,Meeting,2005-12-29T05:00:00Z,2005,12,2005-12-27T05:00:00Z,2006-03-27T04:59:59Z,2025-10-17T19:51:43Z,E5-7876,0,0,0900006480450dda
FDA-2005-N-0162-0040,FDA,FDA-2005-N-0162,"Transcript of the November 2, 2005 Hearing",Other,TR-Transcript,2005-12-29T05:00:00Z,2005,12,,,2008-04-11T23:50:43Z,,0,0,0900006480440849
FDA-2005-N-0468-0002,FDA,FDA-2005-N-0468,Designation of New Animal Drugs for Minor Uses or Minor Species; Reopening of the Comment Period,Proposed Rule,Reopening of Comment Period,2005-12-29T05:00:00Z,2005,12,2005-12-27T05:00:00Z,2006-01-28T04:59:59Z,2016-01-12T17:25:33Z,,0,0,0900006480450e0a
FDA-2005-N-0044-0002,FDA,FDA-2005-N-0044,"Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Reporting: Manufacturer Reporting, Importer Reporting, User Facility Reporting, and Distributor Reporting",Notice,60 Day Proposed Information Collection,2005-12-29T05:00:00Z,2005,12,2005-12-23T05:00:00Z,2006-02-03T04:59:59Z,2025-10-17T19:03:49Z,E5-7726,0,0,090000648043eafe
FDA-2005-N-0162-0039,FDA,FDA-2005-N-0162,"Transcript of the November 2, 2005 Hearing",Other,TR-Transcript,2005-12-29T05:00:00Z,2005,12,,,2008-04-11T23:50:47Z,,0,0,0900006480440848
FDA-2004-P-0336-0004,FDA,FDA-2004-P-0336,FDA,Notice,NIR-Notice of Interim Rule,2005-12-29T05:00:00Z,2005,12,2005-12-23T05:00:00Z,2006-03-09T04:59:59Z,2008-04-12T00:49:18Z,,0,0,09000064804732ca
FDA-2005-P-0125-0003,FDA,FDA-2005-P-0125,Letter from FDA CDER to James Salsman,Other,LET-Letter,2005-12-28T05:00:00Z,2005,12,,,2024-12-13T20:23:06Z,,0,0,090000648043fc4f
FDA-2005-P-0426-0004,FDA,FDA-2005-P-0426,Acknowledgment Letter from FDA DDM to Sidley Austin Brown & Wood LLP,Other,Acknowledgement Letter/Receipt,2005-12-28T05:00:00Z,2005,12,,,2025-04-25T12:54:24Z,,0,0,0900006480450259
FDA-2005-P-0128-0003,FDA,FDA-2005-P-0128,Letter from FDA CFSAN to Quaker Oats Company,Other,Letter(s),2005-12-28T05:00:00Z,2005,12,,,2025-04-21T13:57:08Z,,0,0,090000648043fcb6
FDA-2005-P-0426-0003,FDA,FDA-2005-P-0426,Acknowledgment Letter from FDA DDM to Sidley Austin Brown & Wood LLP,Other,Acknowledgement Letter/Receipt,2005-12-28T05:00:00Z,2005,12,,,2025-04-25T12:52:39Z,,0,0,0900006480450258
FDA-2005-P-0372-0003,FDA,FDA-2005-P-0372,"Petition Denial from FDA Associate Commissioner for Regulatory Affairs to Bell, Boyd & Lloyd LLC",Other,Denial,2005-12-28T05:00:00Z,2005,12,,,2025-03-14T19:15:35Z,,0,0,090000648044b55d
FDA-2005-D-0084-0004,FDA,FDA-2005-D-0084,FDA,Notice,NAD-Notice of Availability of Data,2005-12-27T05:00:00Z,2005,12,2005-12-22T05:00:00Z,2006-03-14T04:59:59Z,2008-04-11T23:46:31Z,,0,0,090000648043f444
FDA-2005-D-0084-0001,FDA,FDA-2005-D-0084,FDA,Notice,NAD-Notice of Availability of Data,2005-12-27T05:00:00Z,2005,12,2005-12-22T05:00:00Z,2006-03-14T04:59:59Z,2008-04-11T23:46:31Z,,0,0,090000648043f435
FDA-2003-P-0072-0007,FDA,FDA-2003-P-0072,FDA Regulations Policy & Management Staff to the Division of Dockets Management - Memorandum,Other,M-Memorandum,2005-12-27T05:00:00Z,2005,12,,,2008-06-02T19:08:15Z,,0,0,0900006480482076
FDA-2003-V-0187-0003,FDA,FDA-2003-V-0187,FDA/CDRH to Heritage Planetarium  - Approval for Variance,Other,VRA-Approval for Variance,2005-12-27T05:00:00Z,2005,12,,,2013-07-27T20:55:15Z,,0,0,090000648048a9fe
FDA-2005-D-0227-0001,FDA,FDA-2005-D-0227,"Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Availability (Edition 2)",Notice,NAD-Notice of Availability of Data,2005-12-27T05:00:00Z,2005,12,2005-12-23T05:00:00Z,2006-12-28T04:59:59Z,2008-07-09T14:52:06Z,,0,0,090000648044205e
FDA-2005-D-0084-0003,FDA,FDA-2005-D-0084,Supporting Document for Recommended Maximum Level for Lead in Candy,Supporting & Related Material,REF-Reference (internal unless indicated),2005-12-27T05:00:00Z,2005,12,,,2008-04-11T23:46:31Z,,0,0,090000648043f443
FDA-2005-V-0447-0003,FDA,FDA-2005-V-0447,Spectronika Ltd. - Approval for Variance,Other,VRA-Approval for Variance,2005-12-27T05:00:00Z,2005,12,,,2008-10-03T18:11:05Z,,0,0,0900006480450688
FDA-2005-N-0469-0001,FDA,FDA-2005-N-0469,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reclassification Petitions for Medical Devices,Notice,30 Day Proposed Information Collection,2005-12-27T05:00:00Z,2005,12,2005-12-23T05:00:00Z,,2025-10-08T01:51:00Z,E5-7804,0,0,0900006480450e3e
FDA-2000-P-0097-0003,FDA,FDA-2000-P-0097,"Memorandum from Regulations & Policy Management Staff to Division of Dockets Management (HFA-305), Dated 12/23/2005",Other,Memorandum,2005-12-27T05:00:00Z,2005,12,,,2021-11-30T15:39:34Z,,0,0,09000064804b828d
FDA-2005-D-0084-0002,FDA,FDA-2005-D-0084,Guidance,Supporting & Related Material,GDL-Guidance,2005-12-27T05:00:00Z,2005,12,,,2008-04-11T23:46:31Z,,0,0,090000648043f442
FDA-2005-D-0227-0002,FDA,FDA-2005-D-0227,"Guidance for Industry - Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2) - Final Guidance",Other,GDL-Guidance (Supporting and Related Materials),2005-12-27T05:00:00Z,2005,12,2005-12-27T15:46:28Z,,2024-11-12T04:12:33Z,,1,0,0900006480442062
FDA-2005-P-0059-0007,FDA,FDA-2005-P-0059,FDA/CDER to Williams & Connolly LLP,Other,LET-Letter,2005-12-27T05:00:00Z,2005,12,,,2008-04-12T00:07:52Z,,0,0,090000648043f057
FDA-2002-N-0031-0063,FDA,FDA-2002-N-0031,The Honorable Jim Bunning to the Food and Drug Administration - Letter,Other,LET-Letter,2005-12-23T05:00:00Z,2005,12,,,2008-04-23T20:31:09Z,,0,0,090000648048a4b5
FDA-2005-N-0096-0001,FDA,FDA-2005-N-0096,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications",Notice,Withdrawal,2005-12-23T05:00:00Z,2005,12,2005-12-15T05:00:00Z,,2025-06-19T01:11:14Z,,0,0,090000648043f7c3
FDA-2002-N-0031-0052,FDA,FDA-2002-N-0031,The Honorable John E. Peterson to the Food and Drug Administration - Letter,Other,LET-Letter,2005-12-23T05:00:00Z,2005,12,,,2008-04-23T20:25:01Z,,0,0,090000648048a47f
FDA-2003-N-0154-0004,FDA,FDA-2003-N-0154,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Research Study
Complaint Form",Notice,30 Day Proposed Information Collection,2005-12-23T05:00:00Z,2005,12,2005-12-16T05:00:00Z,2006-01-18T04:59:59Z,2025-03-12T13:12:59Z,05-24102,0,0,090000648048760b
FDA-2002-N-0031-0051,FDA,FDA-2002-N-0031,The Honorable John E. Peterson to the Food and Drug Administration - Letter,Other,LET-Letter,2005-12-23T05:00:00Z,2005,12,,,2008-04-23T20:23:27Z,,0,0,090000648048a478
FDA-2004-H-0391-0113,FDA,FDA-2004-H-0391,FDA/DDM,Other,CS-Certificate of Service,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:50Z,,0,0,0900006480474367
FDA-1976-N-0027-0022,FDA,FDA-1976-N-0027,Notice of Proposed Rule-Making re (OTC) nasal decongestant and weight control drug products containing phenylpropanolamine preparations.,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2005-12-22T05:00:00Z,2005,12,2005-12-21T05:00:00Z,2006-03-23T04:59:59Z,2015-11-10T21:40:23Z,,0,0,090000648051b798
FDA-2004-H-0391-0112,FDA,FDA-2004-H-0391,HF-3,Rule,SET-Settlement Agreement,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:52Z,,0,0,0900006480474366
FDA-2004-H-0391-0114,FDA,FDA-2004-H-0391,HF-3,Rule,SET-Settlement Agreement,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:51Z,,0,0,0900006480474368
FDA-2005-P-0008-0001,FDA,FDA-2005-P-0008,Number not used,Other,ACK-Acknowledgement Letter,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:07:27Z,,0,0,090000648043e3b8
FDA-2004-P-0223-0005,FDA,FDA-2004-P-0223,FDA - Notice of Meeting,Notice,NM-Notice of Meeting,2005-12-22T05:00:00Z,2005,12,2005-12-21T05:00:00Z,2006-03-11T04:59:59Z,2009-04-21T19:53:09Z,,0,0,0900006480471211
FDA-2005-D-0335-0008,FDA,FDA-2005-D-0335,FDA,Notice,N-Notice,2005-12-22T05:00:00Z,2005,12,2005-12-21T05:00:00Z,2006-01-24T04:59:59Z,2008-04-11T23:47:17Z,,0,0,0900006480448cf9
FDA-2005-N-0240-0002,FDA,FDA-2005-N-0240,Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Public Health Notification (formerly known as Safety Alert/Public Health Advisory) Readership Survey,Notice,60 Day Proposed Information Collection,2005-12-22T05:00:00Z,2005,12,2005-12-21T05:00:00Z,2006-02-22T04:59:59Z,2025-10-17T19:36:13Z,E5-7642,0,0,09000064804440ae
FDA-2004-H-0391-0110,FDA,FDA-2004-H-0391,GCF-1,Rule,SET-Settlement Agreement,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:49Z,,0,0,0900006480474364
FDA-2004-H-0391-0111,FDA,FDA-2004-H-0391,GCF-1,Rule,SET-Settlement Agreement,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:50Z,,0,0,0900006480474365
FDA-2004-H-0391-0115,FDA,FDA-2004-H-0391,FDA/DDM,Other,CS-Certificate of Service,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:51Z,,0,0,0900006480474369
FDA-2005-P-0436-0003,FDA,FDA-2005-P-0436,number not used,Other,ACK-Acknowledgement Letter,2005-12-21T05:00:00Z,2005,12,,,2008-04-12T00:10:37Z,,0,0,090000648045046d
FDA-2005-P-0057-0003,FDA,FDA-2005-P-0057,"Acknowledgment Letter from FDA DDM to Hyman, Phelps & McNamara, P.C",Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-04-24T16:28:00Z,,0,0,090000648043ee1c
FDA-2005-P-0057-0002,FDA,FDA-2005-P-0057,"Acknowledgment Letter from FDA DDM to Hyman, Phelps & McNamara, P.C",Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-04-24T16:26:37Z,,0,0,090000648043ee1b
FDA-2005-N-0291-0001,FDA,FDA-2005-N-0291,Regulatory Process for Pediatric Mechanical Circulatory Support Devices (Ventricular Assist Devices),Notice,Meeting,2005-12-21T05:00:00Z,2005,12,2005-12-19T05:00:00Z,,2025-10-17T19:21:08Z,05-24271,0,0,0900006480445d51
FDA-1980-N-0049-0163,FDA,FDA-1980-N-0049,Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Notice,Notice of Final Rule,2005-12-21T05:00:00Z,2005,12,2005-12-15T05:00:00Z,,2020-09-25T13:40:57Z,05-24224,0,0,09000064805ba0aa
FDA-2005-P-0057-0001,FDA,FDA-2005-P-0057,"Acknowledgment Letter from FDA DDM to Hyman, Phelps & McNamara, P.C",Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-04-24T16:25:27Z,,0,0,090000648043ee10
FDA-2005-V-0452-0002,FDA,FDA-2005-V-0452,Acknowledgement Letter to Night Vision Equipment Company,Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-11-06T02:29:53Z,,0,0,09000064804507b5
FDA-2005-V-0452-0001,FDA,FDA-2005-V-0452,Duplicate - Acknowledgement Letter to Night Vision Equipment Company,Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-11-06T02:29:00Z,,0,0,09000064804507b0
FDA-1980-N-0049-0162,FDA,FDA-1980-N-0049,Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Notice,General Notice,2005-12-21T05:00:00Z,2005,12,2005-12-15T05:00:00Z,,2020-09-25T13:43:01Z,05-24223,0,0,09000064805ba0a9
FDA-2005-N-0040-0005,FDA,FDA-2005-N-0040,"Agenda for November 17, 2005 Stakeholder Meeting",Other,LST-List,2005-12-20T05:00:00Z,2005,12,,,2008-04-11T23:49:32Z,,0,0,090000648043eab4
FDA-2005-P-0133-0001,FDA,FDA-2005-P-0133,HFA-305 to Mayne Pharma (USA) Inc.,Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:08:30Z,,0,0,090000648043fe0e
FDA-2005-P-0133-0002,FDA,FDA-2005-P-0133,HFA-305 to Mayne Pharma (USA) Inc.,Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:08:30Z,,0,0,090000648043fe15
FDA-2005-P-0436-0001,FDA,FDA-2005-P-0436,"HFA-305 to Vigconic (International), Ltd.",Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:10:37Z,,0,0,0900006480450443
FDA-2005-P-0436-0002,FDA,FDA-2005-P-0436,"HFA-305 to Vigconic (International), Ltd.",Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:10:37Z,,0,0,090000648045046b
FDA-1999-N-0113-0174,FDA,FDA-1999-N-0113,"Transcript of the August 13, 2005 Meeting",Other,TR-Transcript,2005-12-20T05:00:00Z,2005,12,,,2008-04-25T00:17:45Z,,0,0,09000064804ae8c5
FDA-1999-N-0113-0175,FDA,FDA-1999-N-0113,"Transcript of the August 13, 2005 Meeting",Other,TR-Transcript,2005-12-20T05:00:00Z,2005,12,,,2008-04-25T00:17:46Z,,0,0,09000064804ae8c6
FDA-2005-P-0366-0002,FDA,FDA-2005-P-0366,Acknowledgement Letter from FDA DDM to Keller and Heckman LLP,Other,Acknowledgement Letter/Receipt,2005-12-20T05:00:00Z,2005,12,,,2025-04-24T18:29:38Z,,0,0,090000648044af31
FDA-2005-P-0366-0001,FDA,FDA-2005-P-0366,Acknowledgement Letter from FDA DDM to Keller and Heckman LLP,Other,Acknowledgement Letter/Receipt,2005-12-20T00:00:00Z,2005,12,,,2025-05-09T01:17:11Z,,0,0,090000648044aec8
FDA-2005-P-0070-0005,FDA,FDA-2005-P-0070,Acknowledgment Letter from FDA DDM to Scientific Laboratory Products,Other,Acknowledgement Letter/Receipt,2005-12-19T05:00:00Z,2005,12,,,2024-12-13T15:10:16Z,,0,0,090000648043f2f3
FDA-2005-P-0124-0003,FDA,FDA-2005-P-0124,"Letter from FDA CDER to Pharmaceutical Patent Attorneys, LLC",Other,LET-Letter,2005-12-16T05:00:00Z,2005,12,,,2024-12-13T15:34:04Z,,0,0,090000648043fc3d
FDA-2005-N-0281-0007,FDA,FDA-2005-N-0281,"Agenda for December 7-8, 2005 Hearing",Other,LST-List,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:34Z,,0,0,0900006480444c01
FDA-2005-N-0281-0009,FDA,FDA-2005-N-0281,List of Attendees for 12/7-8/2005 Public Meeting,Other,LST-List,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:48Z,,0,0,0900006480444c17
FDA-2005-N-0281-0006,FDA,FDA-2005-N-0281,"Agenda for December 7-8, 2005 Hearing",Other,LST-List,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:36Z,,0,0,0900006480444c00
FDA-2005-N-0281-0008,FDA,FDA-2005-N-0281,"Director, Center for Drugs Evaluation and Research, FDA",Other,TS-Testimony,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:31Z,,0,0,0900006480444c02
FDA-2005-P-0061-0003,FDA,FDA-2005-P-0061,Letter from FDA CFSAN to Alaska Birch Syrupmakers Association,Other,LET-Letter,2005-12-16T05:00:00Z,2005,12,,,2024-12-16T21:58:23Z,,0,0,090000648043f0ff
FDA-2005-D-0287-0001,FDA,FDA-2005-D-0287,FDA,Notice,NAD-Notice of Availability of Data,2005-12-15T05:00:00Z,2005,12,2005-12-13T05:00:00Z,,2008-04-11T23:47:13Z,,0,0,09000064804458bf
FDA-1980-N-0049-0124,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T17:26:17Z,,0,0,09000064805ba082
FDA-1980-N-0049-0142,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T14:47:53Z,,0,0,09000064805ba095
FDA-1980-N-0049-0144,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T13:18:41Z,,0,0,09000064805ba097
FDA-1980-N-0049-0146,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T20:08:05Z,,0,0,09000064805ba099
FDA-1980-N-0049-0156,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T19:47:03Z,,0,0,09000064805ba0a3
FDA-1980-N-0049-0137,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T14:46:44Z,,0,0,09000064805ba08f
FDA-1980-N-0049-0155,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T20:24:38Z,,0,0,09000064805ba0a2
FDA-1980-N-0049-0157,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T20:45:00Z,,0,0,09000064805ba0a4
FDA-1980-N-0049-0127,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T17:41:35Z,,0,0,09000064805ba085
FDA-1980-N-0049-0154,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T20:21:37Z,,0,0,09000064805ba0a1
FDA-1980-N-0049-0141,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T21:02:42Z,,0,0,09000064805ba093
FDA-2005-D-0287-0002,FDA,FDA-2005-D-0287,Guideline,Supporting & Related Material,GDL-Guidance,2005-12-15T05:00:00Z,2005,12,,,2008-04-11T23:47:13Z,,0,0,09000064804458f7
FDA-1980-N-0049-0139,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T14:47:11Z,,0,0,09000064805ba091
FDA-1980-N-0049-0149,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T13:37:37Z,,0,0,09000064805ba09c
FDA-1980-N-0049-0159,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T20:49:10Z,,0,0,09000064805ba0a6
FDA-1980-N-0049-0126,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T17:37:32Z,,0,0,09000064805ba084
FDA-1980-N-0049-0130,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T14:44:46Z,,0,0,09000064805ba088
FDA-1980-N-0049-0132,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T19:44:09Z,,0,0,09000064805ba08a
FDA-1980-N-0049-0134,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T20:02:28Z,,0,0,09000064805ba08c
FDA-1980-N-0049-0138,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T14:46:59Z,,0,0,09000064805ba090
FDA-1980-N-0049-0148,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T13:31:39Z,,0,0,09000064805ba09b
FDA-2004-N-0052-0005,FDA,FDA-2004-N-0052,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Food and Drug Administration Recall Regulations (Guidelines),Notice,Notice of Approval,2005-12-15T05:00:00Z,2005,12,,,2025-09-26T22:19:26Z,05-24042,0,0,090000648046e8d8
FDA-1980-N-0049-0129,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T18:54:03Z,,0,0,09000064805ba087
FDA-1980-N-0049-0143,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-15T13:14:43Z,,0,0,09000064805ba096
FDA-1980-N-0049-0151,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T19:51:46Z,,0,0,09000064805ba09e
FDA-1980-N-0049-0153,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T20:17:12Z,,0,0,09000064805ba0a0
FDA-1980-N-0049-0136,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T20:14:58Z,,0,0,09000064805ba08e
FDA-1980-N-0049-0150,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review (Non-AVA); Final Rule and Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-09T19:50:51Z,,0,0,09000064805ba09d
FDA-2005-N-0470-0002,FDA,FDA-2005-N-0470,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reprocessed Single-Use Device Labeling,Notice,30 Day Proposed Information Collection,2005-12-15T05:00:00Z,2005,12,,,2025-10-08T19:51:34Z,05-24041,0,0,0900006480450e57
FDA-2005-N-0099-0017,FDA,FDA-2005-N-0099,"Transcript of the November 14, 2005 meeting",Other,TR-Transcript,2005-12-15T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f859
FDA-1980-N-0049-0125,FDA,FDA-1980-N-0049,Background Information re Biological Products; Bacterial Vaccines and Toxiods; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Supporting & Related Material,Background Material,2005-12-15T05:00:00Z,2005,12,,,2020-09-10T17:32:47Z,,0,0,09000064805ba083